Patents by Inventor Michal LUZAC

Michal LUZAC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HISTONE ACETYLTRANSFERASE MODULATORS AND USES THEREOF
    Publication number: 20180244603
    Abstract: The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels and/or accumulations of alpha-synuclein as well as cancer by administering a compound hat modulates HAT to a subject.
    Type: Application
    Filed: May 1, 2018
    Publication date: August 30, 2018
    Inventors: Yitshak FRANCIS, Mauro FA, Ottavio ARANCIO, Jole FIORITO, Shixian DENG, Donald W. LANDRY, Michal LUZAC, Yan FENG
  • Histone acetyltransferase modulators and uses thereof
    Patent number: 9969677
    Abstract: The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: May 15, 2018
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Yitshak Francis, Mauro Fa, Ottavio Arancio, Jole Fiorito, Shixian Deng, Donald W. Landry, Michal Luzac, Yan Feng
  • HISTONE ACETYLTRANSFERASE MODULATORS AND USES THEREOF
    Publication number: 20170121276
    Abstract: The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.
    Type: Application
    Filed: December 22, 2011
    Publication date: May 4, 2017
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Yitshak FRANCIS, Mauro FA, Ottavio ARANCIO, Jole FIORITO, Shixian DENG, Donald W. LANDRY, Michal LUZAC, Yan FENG